Document Detail


Effects of nitric oxide inhibition on basal forearm blood flow in patients with nonischemic chronic heart failure.
MedLine Citation:
PMID:  10328184     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Increased peripheral vascular tone in patients with chronic heart failure (CHF) is an important factor which contributes to increased cardiac afterload and reduced exercise capacity, and consequent further deterioration in CHF. The role of endogenous nitric oxide (NO) in the regulation of basal vascular tone in CHF is controversial. This study has investigated (1) whether basal NO bioavailability is reduced in the peripheral vasculature of patients with nonischemic CHF in the absence of confounding factors influencing endothelial function, and (2) if a difference is found, what clinical characteristics are related to the decreased NO-dependent vasodilation. Basal forearm blood flow (FBF) of 12 patients with CHF and 14 healthy volunteers was measured before and after administration of N(G)-monomethyl-L-arginine (L-NMMA) by venous occlusion plethysmography. After L-NMMA administration, basal FBF in both healthy subjects and patients with CHF decreased significantly, with the decrease in CHF patients being less than that in healthy volunteers (-0.7+/-0.2 vs -1.5+/-0.2 ml/min per 100 ml tissue, P < 0.01). When both groups were considered together, basal FBF was closely related to the decrease in FBF after L-NMMA administration (r = -0.83. P < 0.001). When CHF patients were divided into two groups according to NYHA class, the L-NMMA-induced decrease in FBF in moderate CHF (NYHA III; n = 7) was significantly less than that in mild CHF (NYHA II; n = 5) (-0.36+/-0.13 vs -1.16+/-0.72 ml/min per 100 ml tissue, P < 0.05). In conclusion, basal bioavailability of NO in the peripheral vascular bed in nonischemic CHF is impaired, with an increase in basal vascular tone and with progression of this disorder. This suggests that impaired basal NO bioactivity may make an important contribution to the elevated peripheral vascular tone and expression of symptoms seen in CHF.
Authors:
H Yoshida; M Nakamura; T Akatsu; N Arakawa; K Hiramori
Related Documents :
21177844 - Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias.
6933324 - Attendance failure at paediatric medical outpatient clinics.
21373184 - The hla class ii allele drb1*1501 is over-represented in patients with idiopathic pulmo...
17521504 - Tips and tricks on outpatient initiation and uptitration of beta-blockade in heart fail...
24302934 - Comparison of cardiovascular risk factors and biochemical profile in patients with card...
8122534 - Soft cervical disc herniation: a retrospective study of 100 cases.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Heart and vessels     Volume:  13     ISSN:  0910-8327     ISO Abbreviation:  Heart Vessels     Publication Date:  1998  
Date Detail:
Created Date:  1999-07-12     Completed Date:  1999-07-12     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8511258     Medline TA:  Heart Vessels     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  142-6     Citation Subset:  IM    
Affiliation:
Second Department of Internal Medicine, Iwate Medical University, Morioka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Flow Velocity
Enzyme Inhibitors / pharmacology
Female
Forearm / blood supply*
Heart Failure / blood,  drug therapy,  physiopathology*
Humans
Infusions, Intra-Arterial
Male
Middle Aged
Nitric Oxide / antagonists & inhibitors*,  biosynthesis
Nitric Oxide Synthase / antagonists & inhibitors*
Reproducibility of Results
Vascular Resistance
omega-N-Methylarginine / pharmacology
Chemical
Reg. No./Substance:
0/Enzyme Inhibitors; 10102-43-9/Nitric Oxide; 17035-90-4/omega-N-Methylarginine; EC 1.14.13.39/Nitric Oxide Synthase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The hemodynamic impact of diffuse myocardial ischemic lesions: an animal experimental model based on...
Next Document:  Reduced release of tissue factor by application of a centrifugal pump during cardiopulmonary bypass.